<DOC>
	<DOCNO>NCT00746681</DOCNO>
	<brief_summary>Tolterodine approve use treatment overactive bladder ( OAB ) . The study design investigate whether pregabalin may efficacy OAB whether efficacy alter combined tolterodine .</brief_summary>
	<brief_title>Investigation Tolterodine , Pregabalin Tolterodine - Pregabalin Combination Treatment Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Women &gt; 18 year Old Diagnosis OAB ( micturition frequency &gt; /= 8 time per day ; urinary urgency &gt; /= 4 time per week ) Subjects symptoms overactive bladder le 6 month prior randomization . Significant stress incontinence determine investigator e.g . stress predominant mixed incontinence , positive cough provocation test . Subjects condition would contraindicate use tolterodine pregabalin , include : Uncontrolled narrow angle glaucoma ; Urinary retention ; Myasthenia gravis ; Gastric retention ; Severe ulcerative colitis ; Toxic megacolon ; Rare hereditary problem galactose intolerance ; Fructose intolerance ; Sucroseisomalate insufficiency ; Lapp lactase deficiency ; Glucosegalactose malabsorption .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>